EdgarLookup

Allogene Therapeutics, Inc.

View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 537 filings →
Form Description Date
4 FORM 4 Mar 18, 2026
4 FORM 4 Mar 18, 2026
144 Mar 16, 2026
144 Mar 16, 2026
S-8 S-8 Mar 12, 2026
10-K 10-K Mar 12, 2026
8-K 8-K Mar 12, 2026
4 FORM 4 Mar 4, 2026
144 Mar 2, 2026
SCHEDULE 13G/A Feb 17, 2026

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Beneski Benjamin Machinas SVP, Chief Technical Officer Sale 786 @ $1.22 217,721 Nov 17, 2025
Parker Geoffrey M. CHIEF FINANCIAL OFFICER Sale 36,744 @ $1.26 1,276,796 Oct 21, 2025
MESSEMER DEBORAH M. Sale 36,885 @ $1.42 107,431 Jun 10, 2025
Yoshiyama Annie SVP, Finance Sale 9,601 @ $1.41 130,663 Apr 21, 2025
Chang David D President and CEO Sale 46,668 @ $1.96 5,276,569 Mar 14, 2025
Beneski Benjamin Machinas SVP, Chief Technical Officer Sale 5,488 @ $1.98 218,507 Mar 14, 2025
Beneski Benjamin Machinas SVP, Chief Technical Officer Award / Grant 31,755 223,995 Mar 1, 2025
MESSEMER DEBORAH M. Sale 13,313 @ $2.43 144,316 Feb 18, 2025
Douglas Earl Martin SVP, General Counsel Sale 6,404 @ $1.71 587,848 Feb 3, 2025
Parker Geoffrey M. CHIEF FINANCIAL OFFICER Sale 4,361 @ $1.73 1,301,540 Feb 3, 2025